Literature DB >> 1905322

Effects of FP2 and a mercury resistance plasmid from Pseudomonas aeruginosa PA103 on exoenzyme production.

J Johnson1, R L Warren, A A Branstrom.   

Abstract

Plasmids encoding mercury resistance carried by Pseudomonas aeruginosa PAO1161 and PA103 were found to be involved in regulating the secretion of protease, phospholipase C, and alkaline phosphatase. Previously, mutations in Pseudomonas strains that caused pleiotropic effects on the production of extracellular enzymes were mapped to the bacterial chromosome. We show that pleiotropic changes in extracellular enzyme production can also be regulated by plasmids. In this study, the effects on secretion of exoenzymes by two mercury resistance plasmids, FP2 from PAO1161 and pRLW103 from PA103, were assayed in P. aeruginosa PAO1 and PAO18. The introduction of either plasmid into PAO1 resulted in a significant decrease in exoprotease production. Additionally, pRLW103 significantly increased the production of alkaline phosphatase by both strains. Phospholipase C was produced only in strain PAO18 containing the pRLW103 plasmid. FP2 had no effect on alkaline phosphatase or phospholipase C production in either strain and was found to decrease exoprotease secretion only in strain PAO1. The results indicate the P. aeruginosa mercury resistance plasmids vary in their ability to modify exoenzyme expression, and this ability is influenced by the host strain.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1905322      PMCID: PMC269912          DOI: 10.1128/jcm.29.5.940-944.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Prevalence of Pseudomonas aeruginosa FP plasmids which enhance spontaneous and uv-induced mutagenesis.

Authors:  H W Stokes; V Krishnapillai
Journal:  Mutat Res       Date:  1978-04       Impact factor: 2.433

2.  Host range, entry exclusion, and incompatibility of Pseudomonas aeruginosa FP plasmids.

Authors:  J Finger; V Krishnapillai
Journal:  Plasmid       Date:  1980-05       Impact factor: 3.466

3.  "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

4.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

5.  Genetic mapping and characterization of Pseudomonas aeruginosa mutants defective in the formation of extracellular proteins.

Authors:  B Wretlind; O R Pavlovskis
Journal:  J Bacteriol       Date:  1984-06       Impact factor: 3.490

Review 6.  Genetics of Pseudomonas.

Authors:  B W Holloway
Journal:  Bacteriol Rev       Date:  1969-09

7.  Chromosome mobilization by the R plasmid R68.45: a tool in Pseudomonas genetics.

Authors:  D Haas; B W Holloway
Journal:  Mol Gen Genet       Date:  1978-01-17

8.  Selective inhibition of the accumulation of extracellular proteases of Pseudomonas aeruginosa by gentamicin and tobramycin.

Authors:  R L Warren; N R Baker; J Johnson; M J Stapleton
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

9.  Role of exotoxin and protease as possible virulence factors in experimental infections with Pseudomonas aeruginosa.

Authors:  K Snell; I A Holder; S A Leppla; C B Saelinger
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

10.  Protease phenotypes of Pseudomonas aeruginosa isolated from patients with cystic fibrosis.

Authors:  K S Jagger; D R Bahner; R L Warren
Journal:  J Clin Microbiol       Date:  1983-01       Impact factor: 5.948

View more
  1 in total

1.  Characterization of Pseudomonas aeruginosa-induced MDCK cell injury: glycosylation-defective host cells are resistant to bacterial killing.

Authors:  G Apodaca; M Bomsel; R Lindstedt; J Engel; D Frank; K E Mostov; J Wiener-Kronish
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.